Lalani, Aly-Khan A., et al. “First-Line Sunitinib or Pazopanib in Metastatic Renal Cell Carcinoma: The Canadian Experience”. Canadian Urological Association Journal, vol. 11, no. 3-4, Apr. 2017, pp. 112-7, doi:10.5489/cuaj.4398.